PMC:7102662 / 14196-14420 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T2","span":{"begin":193,"end":200},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T36","span":{"begin":104,"end":109},"obj":"Body_part"},{"id":"T37","span":{"begin":193,"end":200},"obj":"Body_part"}],"attributes":[{"id":"A36","pred":"fma_id","subj":"T36","obj":"http://purl.org/sig/ont/fma/fma67264"},{"id":"A37","pred":"fma_id","subj":"T37","obj":"http://purl.org/sig/ont/fma/fma82743"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":59,"end":63},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T19","span":{"begin":104,"end":109},"obj":"Chemical"},{"id":"T20","span":{"begin":193,"end":200},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A21","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T18","span":{"begin":104,"end":120},"obj":"http://purl.obolibrary.org/obo/GO_0006629"},{"id":"T19","span":{"begin":110,"end":120},"obj":"http://purl.obolibrary.org/obo/GO_0008152"},{"id":"T20","span":{"begin":193,"end":211},"obj":"http://purl.obolibrary.org/obo/GO_0006006"},{"id":"T21","span":{"begin":201,"end":211},"obj":"http://purl.obolibrary.org/obo/GO_0008152"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T118","span":{"begin":0,"end":224},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T251","span":{"begin":59,"end":63},"obj":"SP_10"},{"id":"T252","span":{"begin":104,"end":109},"obj":"CHEBI:18059;CHEBI:18059;GO:0006629"},{"id":"T253","span":{"begin":110,"end":120},"obj":"GO:0006629"},{"id":"T254","span":{"begin":193,"end":200},"obj":"CHEBI:17234;CHEBI:17234;GO:0006006"},{"id":"T255","span":{"begin":201,"end":211},"obj":"GO:0006006"},{"id":"T92830","span":{"begin":77,"end":85},"obj":"SP_7"},{"id":"T27416","span":{"begin":80,"end":85},"obj":"NCBITaxon:10239"},{"id":"T34190","span":{"begin":122,"end":127},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T90459","span":{"begin":127,"end":137},"obj":"NCBITaxon:11632"},{"id":"T6997","span":{"begin":138,"end":143},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T89731","span":{"begin":179,"end":186},"obj":"UBERON:0000948"},{"id":"T12959","span":{"begin":187,"end":192},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"2_test","denotations":[{"id":"32247212-28831119-25241182","span":{"begin":220,"end":222},"obj":"28831119"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"442","span":{"begin":27,"end":35},"obj":"Species"},{"id":"446","span":{"begin":87,"end":120},"obj":"Disease"},{"id":"447","span":{"begin":144,"end":160},"obj":"Disease"},{"id":"448","span":{"begin":185,"end":211},"obj":"Disease"}],"attributes":[{"id":"A442","pred":"tao:has_database_id","subj":"442","obj":"Tax:9606"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"MESH:D052439"},{"id":"A447","pred":"tao:has_database_id","subj":"447","obj":"MESH:D018376"},{"id":"A448","pred":"tao:has_database_id","subj":"448","obj":"MESH:D044882"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]."}